Ping-Chih Ho | |||||||||||||||||||||||||||||||||||||||||
Professor Ping-Chih Ho is a cancer immunologist at the Ludwig Institute for Cancer Research, Lausanne — Switzerland | |||||||||||||||||||||||||||||||||||||||||
His research focuses on immunometabolism in T cells and macrophages. He has made substantial contributions to our understanding of how tumor cells evade immunosurveillance through their metabolism, and how it may be possible to preprogram the metabolic machinery of immune cells to improve immunotherapy. His work is also delineating links between metabolic processes, signaling cascades and epigenetic programming in the activation and differentiation of T cells and macrophages. Ho did his undergraduate and postgraduate training at National Taiwan University and obtained his PhD at the University of Minnesota. He was a post doc at Susan Kaech laboratory at Yale University, before being recruited as an adjunct Ludwig scientist and tenure-track assistant professor in the Department of Oncology at the University of Lausanne.
He became a full member of the Ludwig Institute in 2023 and is currently a full professor at the University of Lausanne. Ho has received several prestigious awards, including the Swiss Bridge Award, Anna Fuller Award, Cancer Research Institute-CLIP investigator award, Melanoma Research Alliance-SITC Young investigator Award, a European Research Council Starting Grant and a Swiss National Science Foundation Consolidator Grant. He is a member of the European Molecular Biology Organization’s Young Investigator Programme. Ho also recently became an elected member of the Henry Kunkel Society which acknowledges scientists who has made substantial impacts for immunology and immunopathology.
|